Marta Sanchez-Carbayo Selected Research

Marta Sanchez-Carbayo Research Topics

Disease

27	Neoplasms (Cancer) 01/2018 - 12/2002
23	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 12/2002
5	Carcinoma (Carcinomatosis) 01/2018 - 03/2011
4	Transitional Cell Carcinoma 03/2008 - 05/2005
3	Non-Muscle Invasive Bladder Neoplasms 10/2015 - 05/2012
3	Neoplasm Metastasis (Metastasis) 04/2012 - 01/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2012
2	Disease Progression 10/2016 - 03/2011
2	Prostatic Neoplasms (Prostate Cancer) 06/2013 - 01/2006
2	Inflammation (Inflammations) 02/2013 - 04/2012
1	Malaria 01/2020
1	Carcinogenesis 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Kidney Neoplasms (Kidney Cancer) 10/2016
1	Carcinoma in Situ 11/2010
1	Hematuria 07/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2005
1	Squamous Cell Carcinoma of Head and Neck 01/2005
1	Osteosarcoma (Osteogenic Sarcoma) 04/2003

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
13	Biomarkers (Surrogate Marker)IBA 10/2016 - 08/2003
4	nuclear matrix protein 22IBA 07/2010 - 05/2005
4	Complementary DNA (cDNA)IBA 01/2005 - 12/2002
3	RNA (Ribonucleic Acid)IBA 06/2013 - 02/2003
2	Proteoglycans (Proteoglycan)IBA 01/2020 - 04/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 08/2012
2	Messenger RNA (mRNA)IBA 06/2013 - 01/2011
2	Protein Isoforms (Isoforms)IBA 04/2012 - 03/2011
2	AntibodiesIBA 03/2011 - 01/2006
2	Caveolin 1IBA 02/2011 - 12/2002
2	Tumor Biomarkers (Tumor Markers)IBA 01/2011 - 03/2008
2	Peptide Hydrolases (Proteases)FDA Link 01/2011 - 01/2006
2	ezrinIBA 11/2009 - 01/2005
2	Blood Proteins (Serum Proteins)IBA 01/2008 - 01/2006
2	OligonucleotidesIBA 02/2006 - 12/2003
2	moesinIBA 01/2005 - 12/2002
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2020
1	Collodion (Nitrocellulose)IBA 01/2020
1	GlycosaminoglycansIBA 01/2020
1	Sirtuin 1IBA 01/2018
1	NAD (NADH)IBA 01/2018
1	Angiogenesis InhibitorsIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Peptide Initiation Factors (Initiation Factor)IBA 06/2013
1	Cyclin AIBA 06/2013
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013
1	Cyclin D1IBA 02/2013
1	Cysteine (L-Cysteine)FDA Link 02/2013
1	CarcinogensIBA 02/2013
1	Therapeutic UsesIBA 08/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2012
1	Polo-Like Kinase 1IBA 05/2012
1	SERPIN-B5 (maspin)IBA 05/2012
1	SurvivinIBA 05/2012
1	Cathepsin EIBA 05/2012
1	Chondroitin Sulfate ProteoglycansIBA 04/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2012
1	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 04/2012
1	Versicans (Versican)IBA 04/2012
1	Profilins (Profilin)IBA 04/2012
1	Phenobarbital (Luminal)FDA Link 03/2011
1	Phosphotransferases (Kinase)IBA 02/2011
1	Endothelin-1 (Endothelin 1)IBA 01/2011
1	Endothelin A ReceptorIBA 01/2011
1	CytokinesIBA 01/2011
1	Cyclin D3IBA 11/2010
1	Dynamins (Dynamin)IBA 01/2010
1	ProteomeIBA 01/2010
1	ClusterinIBA 01/2010
1	GelsolinIBA 11/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	GoldIBA 05/2006
1	SynucleinsIBA 02/2006
1	Exopeptidases (Exopeptidase)IBA 01/2006
1	Peptides (Polypeptides)IBA 01/2006
1	Complement System Proteins (Complement)IBA 01/2006
1	Cytoskeletal ProteinsIBA 01/2005
1	radixinIBA 01/2005
1	B7-2 AntigenIBA 08/2003
1	Ephrin-B3 (Ephrin B3)IBA 04/2003
1	Keratin-10IBA 12/2002

Therapy/Procedure

5	Therapeutics 10/2016 - 09/2006
2	Lasers (Laser) 01/2006 - 12/2003
1	Cystectomy 02/2011